Cargando…

Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility

Detalles Bibliográficos
Autores principales: Fiszer, Dorota, Fisher, Nickla A, Carr, Ian M, Shaw, Marie-Anne, Hopkins, Philip M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139666/
http://dx.doi.org/10.1186/1471-2253-14-S1-A13
_version_ 1782331391767216128
author Fiszer, Dorota
Fisher, Nickla A
Carr, Ian M
Shaw, Marie-Anne
Hopkins, Philip M
author_facet Fiszer, Dorota
Fisher, Nickla A
Carr, Ian M
Shaw, Marie-Anne
Hopkins, Philip M
author_sort Fiszer, Dorota
collection PubMed
description
format Online
Article
Text
id pubmed-4139666
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41396662014-08-22 Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility Fiszer, Dorota Fisher, Nickla A Carr, Ian M Shaw, Marie-Anne Hopkins, Philip M BMC Anesthesiol Oral Presentation BioMed Central 2014-08-18 /pmc/articles/PMC4139666/ http://dx.doi.org/10.1186/1471-2253-14-S1-A13 Text en Copyright © 2014 Fiszer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Fiszer, Dorota
Fisher, Nickla A
Carr, Ian M
Shaw, Marie-Anne
Hopkins, Philip M
Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
title Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
title_full Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
title_fullStr Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
title_full_unstemmed Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
title_short Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
title_sort advantage from massive parallel sequencing of ryr1 and cacna1s in diagnostics of malignant hyperthermia susceptibility
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139666/
http://dx.doi.org/10.1186/1471-2253-14-S1-A13
work_keys_str_mv AT fiszerdorota advantagefrommassiveparallelsequencingofryr1andcacna1sindiagnosticsofmalignanthyperthermiasusceptibility
AT fishernicklaa advantagefrommassiveparallelsequencingofryr1andcacna1sindiagnosticsofmalignanthyperthermiasusceptibility
AT carrianm advantagefrommassiveparallelsequencingofryr1andcacna1sindiagnosticsofmalignanthyperthermiasusceptibility
AT shawmarieanne advantagefrommassiveparallelsequencingofryr1andcacna1sindiagnosticsofmalignanthyperthermiasusceptibility
AT hopkinsphilipm advantagefrommassiveparallelsequencingofryr1andcacna1sindiagnosticsofmalignanthyperthermiasusceptibility